Business Context and Reporting Period
Company: Boston Scientific Corporation (BSX)
Filing Type: Form 8-K (Current Report)
Report Date: February 4, 2026
Reporting Period: Fourth quarter and full year ended December 31, 2025
This filing serves as a notification that the company issued a press release announcing financial results for the specified period. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data. Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release but does not include the text of management commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 4, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific details of the fourth quarter and full-year 2025 performance against prior year guidance.
- Check for any updated forward-looking guidance or outlook statements in the press release.
- Confirm the status of the 0.625% Senior Notes due 2027 (BSX27) listed as registered securities.